NIH grant will help launch the ALL ALS research consortium
The Barrow Neurological Institute has received $16.7 million from the National Institutes of Health (NIH) to help coordinate a nationwide…
Articles by Patricia Inácio, PhD
PrimeC boosts survival of motor neurons derived from ALS patients
PrimeC, NeuroSense Therapeutics‘ investigational, fixed-dose combination therapy for amyotrophic lateral sclerosis (ALS), significantly boosted the survival of…
New EAP will allow pridopidine use for ALS patients not in trial
Amyotrophic lateral sclerosis (ALS) patients not eligible to participate in clinical trials of pridopidine — a small molecule…
Early 2024 eyed for approval decision in EU on masitinib for ALS
The European Medicines Agency (EMA) is now expected to issue a decision in the first months of 2024 on the…
Spinal taps can be given safely to ALS patients, small study reports
People with amyotrophic lateral sclerosis (ALS) are not at a higher risk of complications due to a spinal tap…
Early Radicava lowers ventilation, hospitalization, mortality risk
Early treatment with Radicava (edaravone), an approved therapy for amyotrophic lateral sclerosis (ALS), significantly reduced the risk of…
Grant supports animal testing of RNA molecules in familial ALS
A grant given to a researcher at the University of Albany in New York will support further work into specific…
Application filed in Australia to launch first trial of ARO-SOD1
Arrowhead Pharmaceuticals has filed an application in Australia seeking the green light to launch the first clinical trial of…
Omega-3 fatty acid tied to slower ALS progression, better survival
High blood levels of an omega-3 fatty acid is associated with a significantly slower disease progression and longer life among…
BrainTale funding will accelerate imaging analysis platform
The French medtech company BrainTale has raised €4.5 million (about $4.9 million) to support the development of a noninvasive…